Synaptosomal-Associated Protein 25 Gene Polymorphisms Affect Treatment Efficiency of Methylphenidate in Children With Attention-Deficit Hyperactivity Disorder: An fNIRS Study

Methylphenidate (MPH) is the first-line drug for the treatment of children with attention-deficit hyperactivity disorder (ADHD); however, individual curative effects of MPH vary. Many studies have demonstrated that synaptosomal-associated protein 25 (SNAP-25) gene MnlI polymorphisms may be related t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jie, Yan, Wen-Jie, Wu, Yan, Tian, Xin-Xin, Zhang, Yi-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Behavioral Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766417/
https://www.ncbi.nlm.nih.gov/pubmed/35069142
http://dx.doi.org/10.3389/fnbeh.2021.793643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766417/
https://www.ncbi.nlm.nih.gov/pubmed/35069142
http://dx.doi.org/10.3389/fnbeh.2021.793643

Ejemplares similares